Oragenics annual operating margin
2010
2011
2012
2013
2014
2021
2022
2023
Oragenics's operating margin was −55,519.89% for fiscal 2023.
View full Oragenics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −55,519.89% | −44555.27 pp |
| 2022 | 2022-12-31 | −10,964.61% | +7165.70 pp |
| 2021 | 2021-12-31 | −18,130.32% | −17511.49 pp |
| 2014 | 2014-12-31 | −618.82% | +951.58 pp |
| 2013 | 2013-12-31 | −1,570.40% | −636.88 pp |
| 2012 | 2012-12-31 | −933.52% | −424.93 pp |
| 2011 | 2011-12-31 | −508.59% | +95.17 pp |
| 2010 | 2010-12-31 | −603.76% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2023 | 2023-09-30 | −28,053.12% | −16192.82 pp |
| Q2 2023 | 2023-06-30 | −23,621.65% | +6943.40 pp |
| Q1 2023 | 2023-03-31 | −17,063.06% | −16271.99 pp |
| Q3 2022 | 2022-09-30 | −4,539.98% | −1918.81 pp |
| Q2 2022 | 2022-06-30 | −11,860.30% | −11503.96 pp |
| Q1 2022 | 2022-03-31 | −30,565.05% | −30007.16 pp |
| Q1 2016 | 2016-03-31 | −791.07% | −276.25 pp |
| Q2 2015 | 2015-06-30 | −2,621.17% | −1994.83 pp |
| Q1 2015 | 2015-03-31 | −356.34% | +411.83 pp |
| Q4 2014 | 2014-12-31 | −557.89% | +148.98 pp |
| Q3 2014 | 2014-09-30 | −514.82% | +3165.69 pp |
| Q2 2014 | 2014-06-30 | −626.34% | +611.39 pp |
| Q1 2014 | 2014-03-31 | −768.17% | +215.99 pp |
| Q4 2013 | 2013-12-31 | −706.87% | −245.14 pp |
| Q3 2013 | 2013-09-30 | −3,680.51% | −2887.10 pp |
| Q2 2013 | 2013-06-30 | −1,237.72% | +1441.10 pp |
| Q1 2013 | 2013-03-31 | −984.16% | −595.52 pp |
| Q4 2012 | 2012-12-31 | −461.74% | −3.96 pp |
| Q3 2012 | 2012-09-30 | −793.41% | −305.01 pp |
| Q2 2012 | 2012-06-30 | −2,678.83% | −2015.83 pp |
| Q1 2012 | 2012-03-31 | −388.64% | +44.41 pp |
| Q4 2011 | 2011-12-31 | −457.78% | +55.32 pp |
| Q3 2011 | 2011-09-30 | −488.40% | +171.01 pp |
| Q2 2011 | 2011-06-30 | −663.00% | — |
| Q1 2011 | 2011-03-31 | −433.05% | — |
| Q3 2010 | 2010-09-30 | −513.10% | — |
| Q2 2010 | 2010-06-30 | −659.41% | — |
Over the last five reported fiscal years, Oragenics's operating margin decreased from −933.52% to −55,519.89%, a change of −54586.37 percentage points. The latest reported quarter, Q3 2023, shows −28,053.12%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oragenics filings at SEC.gov ↗